{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:24:22Z","timestamp":1787221462648,"version":"build-2736575974"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":231,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BioMed Research International"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The dual role of HbA1c in diagnosing and monitoring diabetes mellitus has driven a continuous increase in routine testing requests. To optimize laboratory workflows and avoid dedicated EDTA blood draws, this study is aimed at determining whether fluoride\u2010oxalate and lithium heparin anticoagulant tubes could serve as reliable alternatives to EDTA tubes for HbA1c measurement on the COBAS INTEGRA 400 plus analyzer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Over 2 months at the Pasteur Institute of Tunis, paired blood samples from patients undergoing routine HbA1c testing were analyzed. Standard K3\u2010EDTA tubes were compared with either lithium heparin or fluoride\u2010oxalate tubes using a turbidimetric inhibition immunoassay on a COBAS INTEGRA 400 plus analyzer. The study relied exclusively on residual clinical material without imposing specific preanalytical restrictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study population comprised 277 patients, divided into Group 1 (K3\u2010EDTA vs. fluoride\u2010oxalate,\n                      <jats:italic>n<\/jats:italic>\n                      = 200) and Group 2 (K3\u2010EDTA vs. lithium heparin,\n                      <jats:italic>n<\/jats:italic>\n                      = 77). HbA1c results from both alternative tubes showed strong correlation with K3\u2010EDTA (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.99,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001), with no significant overall differences. Passing\u2013Bablok regression revealed no constant or proportional bias for lithium heparin, whereas a systematic bias was observed for fluoride\u2010oxalate. Bland\u2013Altman analysis of log\u2010transformed data indicated no significant mean bias for either fluoride\u2010oxalate (\u22120.15%; 95% LoA [\u22122.76% to +2.53%]) or lithium heparin (\u22120.04%; 95% LoA [\u22122.77% to +2.76%]), although a slight proportional bias was detected in both. Finally, HbA1c measurements in both tube types exhibited high diagnostic performance at clinical cutoffs (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Fluoride\u2010oxalate and lithium heparin anticoagulant tubes provide reliable alternatives to standard K3\u2010EDTA tubes for HbA1c measurement, with no clinically meaningful differences observed. However, we emphasize that these results are strictly validated for the Roche COBAS immunoassay.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/bmri\/7743935","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:34:28Z","timestamp":1787218468000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluoride\u2010Oxalate and Lithium Heparin Anticoagulant Tubes Are Reliable Alternatives to EDTA for HbA1c Measurement"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9145-5662","authenticated-orcid":false,"given":"Lamia","family":"Abdellaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7422-0686","authenticated-orcid":false,"given":"Asma","family":"Krir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2062-3956","authenticated-orcid":false,"given":"Manel","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aouatef","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8483-9927","authenticated-orcid":false,"given":"Mehdi","family":"Mrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afef","family":"Bahlous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"e_1_2_11_1_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S062"},{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2002.016"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/100.4.371"},{"key":"e_1_2_11_4_2","volume-title":"ISO 15189:2012(en) Medical Laboratories\u2014Requirements for Quality and Competence","author":"International Standards Organization (ISO)","year":"2025"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-012-0198-7"},{"key":"e_1_2_11_6_2","first-page":"107","article-title":"Hemoglobin A1c Levels Obtained From EDTA, Lithium Heparin, Lithium Eeparin Plus Glyceraldehydes, and Sodium Fluoride Blood Samples","volume":"28","author":"Boonlert W.","year":"2010","journal-title":"Songklanagarind Medical Journal"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2014.006"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.20147"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117442"},{"key":"e_1_2_11_10_2","volume-title":"WMA Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks","author":"World Medical Association","year":"2016"},{"key":"e_1_2_11_11_2","volume-title":"Tina-quant HbA1c Gen.","author":"Roche Diagnostics","year":"2025"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0036"},{"key":"e_1_2_11_13_2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S006"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2013.33.6.393"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.148841"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2014-0644"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmv016"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300307"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2007.110"}],"container-title":["BioMed Research International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/bmri\/7743935","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/bmri\/7743935","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/bmri\/7743935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:34:30Z","timestamp":1787218470000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/bmri\/7743935"}},"subtitle":[],"editor":[{"given":"Yoel A.","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/bmri\/7743935"],"URL":"https:\/\/doi.org\/10.1155\/bmri\/7743935","archive":["Portico"],"relation":{},"ISSN":["2314-6133","2314-6141"],"issn-type":[{"value":"2314-6133","type":"print"},{"value":"2314-6141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2026-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"7743935"}}